You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨疫苗股集體大漲,康希諾漲超7%
A股市場疫苗股集體走強,其中,智飛生物20CM漲停,沃森生物漲15%,康泰生物漲超12%,康希諾、華蘭疫苗漲超7%,百克生物漲6%。消息面上,根據廣東省佛山市各區今天下午最新的通報,從7月8日監測發現首例輸入引起的基孔肯雅熱病例以來,截至7月22日,佛山市已有5個區報告了基孔肯雅熱確診病例,累計報告基孔肯雅熱確診病例3195例,主要集中在順德區。另外,世界衛生組織專家就蚊媒傳播疾病基孔肯雅熱發出警報,提醒各國做好應對準備,避免疫情大規模爆發。市場分析人士指出,疫苗股暴漲有多方面因素,一是基孔肯雅熱爆發的消息刺激;二是疫苗板塊在醫藥中沉寂最久,調整最多,籌碼最好;三是疫苗板塊是上一輪醫藥中最早按創新藥邏輯估值的板塊,很多公司管線未給估值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.